Effect of Licorice in COVID-19

Phase 2

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20160316027081N1
• Lead Sponsor: Artesh University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 190

Inclusion Criteria

Admitted patients with COVID-19 in the four hospitals of AJA medical University in Tehran
COVID-19 diagnosed by lung CT or naso-pharyngeal PCR

Exclusion Criteria

Severe hypersensitivity to the Licorice
DKA or NKHC
Pregnancy
Decompensated Cirrhosis
Non viral sepsis
Active GIB
Acute trauma or Surgical problem
Unstable angina or Acute MI
Chronic renal failure with Uremic symptoms

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Admission time. Timepoint: Daily. Method of measurement: Patients' profile (Yes or no).

Secondary Outcome Measures

Name	Time	Method
C-reactive protein. Timepoint: On admission, On discharge. Method of measurement: Laboratory test.;Differences in lymphocyte count. Timepoint: on admission, on discharge. Method of measurement: with the cell counter device.;The death number. Timepoint: at the end of admission. Method of measurement: base on the patient registries.